ReviewIndian pediatrics2025
Advances in Neonatal Seizures (2024): An Update for Pediatricians.
Review in Indian pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe diagnosis and management of seizures and epilepsy syndromes with onset in neonates has undergone several changes following the Internation League against Epilepsy (ILAE) guidelines. To update the Pediatricians regarding the recent advances, this update was planned.
methodsRecently published revised guidelines for neonatal seizures (up to 2024) by ILAE were reviewed and synthesized.
resultsVideo-EEG recording is considered gold standard for diagnosis, with less emphasis on clinical semiology. In resource limited settings, levels of diagnostic certainties may be used. One must be aware of the mandatory, alerts and exclusion criteria for various neonatal-onset epilepsy syndromes. Early neuroimaging facilitates diagnosis. Treatment primarily involves phenobarbitone (PHB) with other drugs to be used in certain special conditions, with universal early stoppage of drugs. Precision therapy is available for some metabolic and genetic etiologies.
conclusionsEEG monitoring in high-risk neonates is the standard of care. PHB still remains the first choice. Early cessation of anti-seizure medications in acute symptomatic seizures is the norm.
Indexed as
Identifiers
40232561What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.